ARO-HIF2

· Arrowhead Pharmaceuticals

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ARO-HIF2, covering 2025-10-09 to 2025-10-09. Get the full timeline:

Most recent: Clinical Trial Update: Study of ARO-HIF2 in Patients With Advanced Clear Cell Renal Cell Carcinoma [Phase 1]